Lorna Renshaw

3.9k total citations
72 papers, 1.9k citations indexed

About

Lorna Renshaw is a scholar working on Cancer Research, Genetics and Oncology. According to data from OpenAlex, Lorna Renshaw has authored 72 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cancer Research, 36 papers in Genetics and 29 papers in Oncology. Recurrent topics in Lorna Renshaw's work include Breast Cancer Treatment Studies (39 papers), Estrogen and related hormone effects (36 papers) and HER2/EGFR in Cancer Research (19 papers). Lorna Renshaw is often cited by papers focused on Breast Cancer Treatment Studies (39 papers), Estrogen and related hormone effects (36 papers) and HER2/EGFR in Cancer Research (19 papers). Lorna Renshaw collaborates with scholars based in United Kingdom, United States and Switzerland. Lorna Renshaw's co-authors include J. Michael Dixon, William R. Miller, E. Jane Macaskill, Mitch Dowsett, Jeremy Thomas, Juliette Murray, Oliver Young, Dean B. Evans, J. Michael Dixon and David Cameron and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Lorna Renshaw

69 papers receiving 1.9k citations

Peers

Countries citing papers authored by Lorna Renshaw

Since Specialization

Citations

This map shows the geographic impact of Lorna Renshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna Renshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna Renshaw more than expected).

Fields of papers citing papers by Lorna Renshaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna Renshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna Renshaw. The network helps show where Lorna Renshaw may publish in the future.

Co-authorship network of co-authors of Lorna Renshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna Renshaw. A scholar is included among the top collaborators of Lorna Renshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna Renshaw. Lorna Renshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer 2022 ·Clinical Cancer Research ·(unknown), Xiaping He, Lorna Renshaw, Carlos Martínez-Pérez, Charlene Kay, Mark Gray, James Meehan, Joel S. Parker, Charles M. Perou, Lisa A. Carey, J. Michael Dixon, Arran Turnbull	11
2	Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies 2019 ·Advances in Therapy ·J. Michael Dixon, David Cameron, Laura Arthur, Deborah Axelrod, Lorna Renshaw, Jeremy Thomas, Arran Turnbull, Oliver Young, (unknown), (unknown), Frederick L. Baehner, Baljit Singh	12
3	Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies 2016 ·Scientific Reports ·(unknown), Laura Arthur, Arran Turnbull, Lorna Renshaw, Vicky S. Sabine, Jeremy Thomas, John M.S. Bartlett, J. Michael Dixon, Andrew H. Sims	12
4	Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer 2015 ·Breast Cancer Research ·Elena López‐Knowles, Paul M Wilkerson, Ricardo Ribas, H Anderson, Alan Mackay, Zara Ghazoui, Aradhana Rani, Peter Osin, A Nerurkar, Lorna Renshaw, Alexey A. Larionov, William R. Miller, J. Michael Dixon, Jorge S. Reis‐Filho, Anita K. Dunbier, Lesley‐Ann Martin, Mitch Dowsett	7
5	Molecular Changes in Lobular Breast Cancers in Response to Endocrine Therapy 2014 ·Cancer Research ·Laura Arthur, Arran Turnbull, (unknown), Alexey A. Larionov, Lorna Renshaw, Charlene Kay, Jeremy Thomas, J. Michael Dixon, Andrew H. Sims	25
6	Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer 2014 ·Breast Cancer Research and Treatment ·Laura Arthur, Arran Turnbull, Lorna Renshaw, (unknown), James Thomas, Timothy R. Wilson, Mark R. Lackner, Andrew H. Sims, J. Michael Dixon	31
7	Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis 2012 ·BMC Medical Genomics ·Arran Turnbull, Robert R. Kitchen, Alexey A. Larionov, Lorna Renshaw, J. Michael Dixon, Andrew H. Sims	35
8	Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial 2010 ·Clinical Cancer Research ·Nigel Bundred, Angela Cramer, Julie Morris, Lorna Renshaw, Kwok‐Leung Cheung, (unknown), (unknown), Oliver Young, Göran Landberg, (unknown), (unknown), A.D. Baildam, Lester Barr, J. Michael Dixon	33
9	Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer 2010 ·Breast Cancer Research and Treatment ·Ruth Board, Andrew Wardley, J. Michael Dixon, Anne Armstrong, Sacha J. Howell, Lorna Renshaw, Emma Donald, Alastair Greystoke, Malcolm Ranson, Andrew Hughes, Caroline Dive	165
10	Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability 2010 ·Breast Cancer Research and Treatment ·J. Michael Dixon, Lorna Renshaw, C. Langridge, Oliver Young, (unknown), Linda Williams, Juliette Murray, E. Jane Macaskill, (unknown), (unknown), Lesley Fallowfield	14
11	The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study 2010 ·Breast Cancer Research and Treatment ·E. Jane Macaskill, John M.S. Bartlett, Vicky S. Sabine, Dana Faratian, Lorna Renshaw, (unknown), Fiona Campbell, (unknown), Linda Williams, Jeremy Thomas, Matthew Barber, J. Michael Dixon	40
12	Increase in response rate by prolonged treatment with neoadjuvant letrozole 2008 ·Breast Cancer Research and Treatment ·J. Michael Dixon, Lorna Renshaw, E. Jane Macaskill, Oliver Young, Juliette Murray, David Cameron, G.R. Kerr, Dean B. Evans, William R. Miller	80
13	Src inhibitors in early breast cancer: a methodology, feasibility and variability study 2008 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Lorna Renshaw, Vivien N. Jacobs, Michael Fennell, (unknown), (unknown), Paul Elvin, Christopher J. Womack, Glen Clack, J. Michael Dixon	15
14	DCIS and aromatase inhibitors 2007 ·The Journal of Steroid Biochemistry and Molecular Biology ·J. Michael Dixon, Dana Faratian, Sharon White, Lorna Renshaw, Juliette Murray, Oliver Young, E. Jane Macaskill, Linda Williams, Jeremy Thomas, Dean B. Evans	6
15	Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer 2007 ·European Journal of Cancer ·(unknown), Lorna Renshaw, E. Jane Macaskill, (unknown), Dana Faratian, James Thomas, J. Michael Dixon	55
16	Aromatase inhibitors—Gene discovery 2007 ·The Journal of Steroid Biochemistry and Molecular Biology ·William R. Miller, Alexey A. Larionov, Lorna Renshaw, Thomas Anderson, Sharon White, Garret M. Hampton, John R. Walker, Steven C. L. Ho, Andreas Krause, Dean B. Evans, J. Michael Dixon	18
17	Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status 2004 ·European Journal of Cancer ·J. Michael Dixon, (unknown), Margaret Hills, Lorna Renshaw, David Cameron, Thomas Anderson, William R. Miller, Mitch Dowsett	32
18	Neoadjuvant tamoxifen and aromatase inhibitors 2003 ·The Journal of Steroid Biochemistry and Molecular Biology ·Michael Dixon, (unknown), Lorna Renshaw, William R. Miller	1
19	Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes 2003 ·The Journal of Steroid Biochemistry and Molecular Biology ·J. Michael Dixon, (unknown), Lorna Renshaw, William R. Miller	39
20	The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer 2000 ·Clinical Cancer Research ·John Dixon, Lorna Renshaw, Christopher Bellamy, Melissa K. Stuart, G Hoctin-Boes, William R. Miller	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact